18F-fluorocholine PET/CT Imaging in Hyperparathyroidism
NCT03203668 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000
Last updated 2017-07-02
Summary
To assess the efficiency of 18F-fluorocholine PET/CT in localization of hyperfunctioning parathyroid tissue in hyperparathyroidism, thereby enabling minimally invasive surgical approaches with fewer complications and comparable success rates
Conditions
- Hyperparathyroidism
Interventions
- RADIATION
-
18F-choline PET/CT
18F-choline PET/CT imaging (neck, mediastinum)
Sponsors & Collaborators
-
Institute of Oncology Ljubljana
collaborator OTHER -
University Medical Centre Ljubljana
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-01
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- Slovenia
Study Locations
More Related Trials
-
Clinical Value of 18F-FCH PET in Localizing Parathyroid Lesions: Comparison With MIBI Scan.
NCT03555487 ·Status: COMPLETED ·Phase: PHASE3
-
[F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors
NCT00707343 ·Status: COMPLETED ·Phase: PHASE1
-
3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx
NCT00757549 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT01179360 ·Status: COMPLETED
-
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
NCT06107374 ·Status: RECRUITING ·Phase: PHASE2
-
Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention
NCT04040946 ·Status: COMPLETED ·Phase: PHASE3
-
Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer
NCT03196518 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
F-18 PSMA for Localization of Parathyroid Adenoma
NCT05299632 ·Status: TERMINATED
-
11C Methionine PET for the Detection of Hyperfunctional Parathyroid Tissues
NCT01783002 ·Status: UNKNOWN ·Phase: PHASE2
-
[18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment
NCT01633255 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody
NCT00606632 ·Status: COMPLETED ·Phase: PHASE3
-
99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT
NCT05891769 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases
NCT06777433 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
18F-fluorocholine and 18F-fluoride PET in Prostate Cancer
NCT04340765 ·Status: COMPLETED ·Phase: NA
-
Treatment of Opioid-refractory Pain (WHO Level III) by Pituitary Radiosurgery
NCT02637479 ·Status: RECRUITING ·Phase: NA
-
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer
NCT04726215 ·Status: UNKNOWN ·Phase: PHASE2
-
Measuring Treatment Response in Metastatic Renal Cell Cancer Using FPIA PET/CT
NCT04802824 ·Status: COMPLETED
-
Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas
NCT02432599 ·Status: COMPLETED ·Phase: PHASE2
-
18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas
NCT04895631 ·Status: COMPLETED ·Phase: PHASE3
-
Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism
NCT06773663 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma
NCT00775268 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Use of PET-MR in Head and Neck Cancer Patients - Diagnostic and Therapeutic Applications
NCT06032663 ·Status: RECRUITING ·Phase: NA
-
Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET
NCT01224873 ·Status: UNKNOWN
-
Evaluation of 18F-FDOPA PET-CT in the Preoperative Initial Assessment of Medullary Thyroid Carcinoma
NCT03636945 ·Status: UNKNOWN ·Phase: NA
-
Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases
NCT03325166 ·Status: TERMINATED ·Phase: PHASE2